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The association between fat consumption and obe-
sity underscores the need to identify physiological
signals that control fat intake. Previous studies
have shown that feeding stimulates small-intestinal
mucosal cells to produce the lipid messenger
oleoylethanolamide (OEA) which, when adminis-
tered as a drug, decreasesmeal frequency by engag-
ing peroxisome proliferator-activated receptors-a
(PPAR-a). Here, we report that duodenal infusion of
fat stimulates OEA mobilization in the proximal small
intestine, whereas infusion of protein or carbohy-
drate does not. OEA production utilizes dietary oleic
acid as a substrate and is disrupted in mutant mice
lacking the membrane fatty-acid transporter CD36.
Targeted disruption of CD36 or PPAR-a abrogates
the satiety response induced by fat. The results sug-
gest that activation of small-intestinal OEA mobiliza-
tion, enabled by CD36-mediated uptake of dietary
oleic acid, serves as amolecular sensor linking fat in-
gestion to satiety.
INTRODUCTION
Feeding stimulates cells in the mucosal layer of duodenum and
jejunum to produce OEA (Fu et al., 2007, 2008), suggesting
that this lipid messenger participates in the induction of satiety.
Consistent with this idea, administration of OEA causes in ro-
dents a marked reduction in food intake, which is both pharma-
cologically and behaviorally selective (Gaetani et al., 2003;
Proulx et al., 2005; Rodrı´guez de Fonseca et al., 2001). This an-
orexic action is accounted for by the ability of OEA to engage
PPAR-a (Fu et al., 2003), a lipid-activated nuclear receptor impli-
cated in regulating the absorption, storage and utilization of die-
tary fat (Bookout et al., 2006; Evans et al., 2004; Lefebvre et al.,
2006). Indeed, the hypophagic effects of exogenous OEA are
abolished by genetic deletion of PPAR-a (Fu et al., 2003), are
closelymimickedbyadministration of syntheticPPAR-aagonists
(Astarita et al., 2006a; Fu et al., 2003), and are accompanied by
changes in the expression of PPAR-a target genes such as theCemembrane lipid transporter CD36 (Fu et al., 2003). Furthermore,
the small-intestinal concentrations reached by OEA after feeding
(100–400 nM) (Fu et al., 2007) are sufficient to fully activate
PPAR-a (median effective concentration, EC50z100 nM) (Astar-
ita et al., 2006a; Fu et al., 2003), but notGPR119 (EC50z3 mM) or
TRPV1 (EC50z2 mM), two receptors that have been also impli-
cated in the pharmacological actions of OEA (Ahern, 2003; Over-
ton et al., 2006).
The molecular steps leading from OEA-dependent activation
of PPAR-a to feeding inhibition are still incompletely understood.
PPAR-a may act by influencing expression of satiety-inducing
proteins such as apolipoprotein A-IV (Nagasawa et al., 2007;
Tso and Liu, 2004; Whited et al., 2005). However, the rapid onset
of the OEA response (<30 min) and its reliance on an intact vagal
sensory innervation suggest the initial involvement of a transcrip-
tion-independent signal that recruits sensory vagal afferents in
the gut (Rodrı´guez de Fonseca et al., 2001). This signal remains
unidentified, though the ability of PPAR-a and other nuclear re-
ceptors to elicit rapid non-genomic responses has been docu-
mented (Bravo et al., 2006; Kumar et al., 2007; LoVerme et al.,
2006; Zanello and Norman, 2004).
Exogenous OEA modulates feeding by prolonging the time in-
terval between meals (Fu et al., 2003; Gaetani et al., 2003; Oveisi
et al., 2004). This mode of action is noteworthy for two reasons.
First, it distinguishes OEA from gut-derived peptides such as
cholecystokinin (CCK), which inhibit food intake by influencing
meal size rather thanmeal timing (Moran, 2006;Wren andBloom,
2007). Second, it is reminiscent of the effects exerted by duode-
nal infusion of dietary fat which, similar to OEA, lowers meal
frequency (Woltman and Reidelberger, 1995) through an as-
yet-uncharacterized mechanism that requires activation of the
sensory vagus (Randich et al., 2000; Tamura and Ritter, 1994;
Woltman et al., 1995). This similarity led us to hypothesize that
OEA mobilization in the proximal small intestine might provide
a functional link between fat ingestion and across-meal satiety.
RESULTS
Dietary Fat Stimulates Small-Intestinal
OEA Mobilization
Infusion of a lipid emulsion (Intralipid, 2 kcal/ml) into the duode-
num of awake catheterized rats, at a rate that mimicked gastricll Metabolism 8, 281–288, October 8, 2008 ª2008 Elsevier Inc. 281
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OEA Links Fat Intake to SatietyFigure 1. Dietary Fat Stimulates OEA Mobilization in Proximal Small Intestine
(A) Effects of duodenal nutrient infusions on jejunal OEA mobilization. NI, No infusion; 1, Intralipid; 2, glucose; 3, peptone; 4, hypertonic saline; 5, isotonic saline.
(B–E) Duodenal infusion of sodium oleate (OA), but not palmitate (PA), regulates jejunal levels of (B) OEA, (C) 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphoe-
thanolamine-N-oleyl (NOPE), (D) NAPE-PLD activity, and (E) FAAH activity.
Infusionswere conducted at 0.5ml/min for 10minwith nutrients equicaloric at 2 kcal/ml. Jejunal tissue was harvested 30min after starting the infusion. Values are
expressed in pmol/g of wet tissue; *p < 0.05; **p < 0.01; ***p < 0.001; n = 5–6 per group. The data present the mean ± SEM.emptying (Kaplan et al., 1997), caused a rapid increase in jejunal
OEA levels, whereas infusion of glucose or amino acid solutions
of equal caloric and osmotic value had no such effect
(Figure 1A). Moreover, control infusions of physiological or
hyperosmotic saline did not alter jejunal OEA content (Figure 1A).
To determine whether free fatty acids generated during lipid
digestion promote OEA formation, we administered emulsions
of monounsaturated oleic acid (C18:1,D9) or saturated palmitic
acid (C16:0) (each at 2 kcal/ml). Oleic acid infusion increased
jejunal OEA levels (Figure 1B), but not those of its saturated
analog palmitoylethanolamide (PEA) (Figure S1A available
online). By contrast, palmitic acid infusion had no effect on either
OEA (Figure 1B) or PEA content (Figure S1B), even though it
significantly increased palmitic acid levels in jejunal tissue
(Figure S1C).
Feeding regulates three distinct steps of OEA metabolism (Fu
et al., 2007): (1) it increases biosynthesis of the OEA precursor,
N-oleoyl-phosphatidylethanolamine (NOPE), catalyzed by an
as-yet-uncharacterized N-acyltransferase (NAT) activity; (2) it
activates the OEA-producing enzyme N-acyl-phosphatidyletha-
nolamine phospholipase D (NAPE-PLD); and (3) it inhibits the
OEA-degrading enzyme fatty-acid amide hydrolase (FAAH).
Oleic acid infusion mimicked all these effects, as it raised jejunal
levels of the representative NOPE species, 1-stearoyl-2-arachi-
donoyl-sn-glycero-3-phosphoethanolamine-N-oleoyl (likely re-
sulting from enhanced NAT activity) (Figure 1C), it stimulated
NAPE-PLD activity (Figure 1D), and it suppressed FAAH activity
(Figure 1E). The results suggest that ingestion of fat, but not
protein or carbohydrate, initiates OEA mobilization in rat duode-
num and jejunum. Notably, duodenal infusion of the unsaturated
constituent of dietary fat, oleic acid, is sufficient to recapitulate
this response.
Postingestive Control of OEA Mobilization
The infusion of lipids into the duodenum bypasses oral sensory
mechanisms that monitor fat availability (Greenberg and Smith,
1996), implying that small-intestinal OEA mobilization is not crit-
ically dependent on cephalic sensors. To further evaluate this
possibility, we used a sham-feeding procedure that gauges the282 Cell Metabolism 8, 281–288, October 8, 2008 ª2008 Elsevier Incimpact of orosensory stimulation on food intake in the absence
of postingestive feedback (Sclafani and Ackroff, 2004). Sham
feeding rats with either a lipid emulsion (Intralipid) or a nutrition-
ally complete liquid diet (Ensure) had no effect on duodenal and
jejunal OEA levels (Figure S2), supporting the suggestion that fat
stimulates OEAmobilization through a postingestive mechanism
localized in the upper gut.
Role of the Lipid Transporter CD36 in OEA Production
How do cells in small-intestinal mucosa detect ingested lipids to
mobilize OEA? We hypothesized that the membrane glycopro-
tein CD36 (Febbraio et al., 2001) may participate in this process
because of its localization to the apical surface of the absorptive
epithelium (Poirier et al., 1996) and its ability to bind long-chain
fatty acids, translocate them across cell membranes (Ehehalt
et al., 2006), and initiate intracellular signaling responses (Huang
et al., 1991). To test this idea, we food deprived wild-type C57/
Bl6mice andCD36 null mice generated on the same background
(Febbraio et al., 1999), and measured small-intestinal OEA and
NOPE contents before and 30 min after re-exposure to food.
As expected from previous data (Fu et al., 2003), wild-type
mice responded to feeding with an increase in OEA and
NOPE levels (Figures 2A and 2C). This response was absent
in mice lacking CD36 (Figures 2B and 2D), indicating that this
protein plays an obligatory function in food-stimulated OEA
production.
Food-Derived Oleic Acid Is a Substrate
for OEA Production
Despite initial uncertainty (Chen et al., 2001; Drover et al., 2005),
the role of CD36 in small-intestinal fatty acid transport is now
firmly established (Nassir et al., 2007). Consistent with such
role, we found that CD36 deletion suppresses oleic-acid uptake
into the duodenum and reduces it in the jejunum of mice that
were fasted for 6 hr and then refed for 30 min (Figures 3A and
3B). This prompted us to examine whether transport of exoge-
nous oleic acid into mucosal cells contributes to OEA biosynthe-
sis. We infused the duodenum of rats with 10Z-heptadecenoic
acid (HDA, C17:1,D10), which chemically resembles oleic acid.
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the fate of this tracer inmucosal lipid extracts by liquid chromatog-
raphy coupled to ion-trap mass spectrometry (LC/MS) (Astarita
et al., 2006b; Fu et al., 2007). HDAwas primarily recovered either
as non-esterified fatty acid (Figure 3C) or as glycerol ester in two
essential constituents of chylomicrons: triacylglycerol and phos-
phatidylcholine (Figure S3; for identifications see Figure S4).
Importantly, HDA infusion was also accompanied by significant
formation of the OEA analog heptadecenoylethanolamide and
its precursor N-10-heptadecenoyl-PE (Figures 3D and 3E; for
identifications see Figure S5). Oral administration of HDA in
wild-type mice yielded similar results (Figures 3F and 3G). By
contrast, intestinal HDA absorption and heptadecenoylethanola-
mide formation were both suppressed inCD36 null mice (Figures
3F and 3G). The results indicate that exogenous HDA is internal-
ized by small-intestinal cells through a CD36-dependent path-
way, and is then targeted to the production of NOPE (catalyzed
by NAT) and the subsequent conversion of NOPE into OEA
(catalyzed by NAPE-PLD). These reactions likely occur in enter-
ocytes, the main mucosal cell type that expresses both CD36
(Poirier et al., 1996) and NAPE-PLD (Fu et al., 2007). We con-
clude, therefore, that dietary oleic acid, in addition to its ability
to regulate enzyme activities involved in the formation and
degradation of OEA (Figures 1C–1E), serves also as metabolic
precursor for enterocyte OEA biosynthesis.
Figure 2. The Fatty-Acid Transporter CD36 Is Required for Small-
Intestinal OEA Production
Refeeding mice (RF) after a 6 hr daytime fast (FD) increases levels of (A) OEA
and (C) 1-stearoyl-2-arachidonoyl-sn-glycerol-3-phosphoethanolamine-N-
oleyl (NOPE) in duodenum (Duod.) and jejunum (Jej.) of wild-type mice (+/+).
No such effect is observed in CD36 null mice (/) (B and D). FD, food-
deprived; RF, 30 min refed; *p < 0.05; **p < 0.01; n = 3–4 per group. The
data present the mean ± SEM.
Figure 3. Internalization of Diet-Derived Oleic Acid by CD36 Enables
OEA Mobilization
Refeeding mice (RF) after a 6 hr daytime fast (FD) increase oleic acid levels in
duodenum (Duod.) and jejunum (Jej.) of wild-type (A), but not CD36 null mice
(B). (C–E) duodenal infusion of the unnatural oleic acid analog 10Z-heptadece-
noic acid (HAD) increases jejunal levels of (C) HDA, (D) heptadecenoylethano-
lamide (HDE), and (E) 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphoetha-
nolamine-N-heptadecenoyl (NAPE). open bars, Vehicle (50 mM Tris buffer);
closed bars, HAD infusion. Infusions were conducted at 0.5 ml/min for 10
min and jejunal tissue was harvested 30 min after starting the infusion. (F
and G) Oral gavage of HDA (200 mg/kg in 1 ml of saline/polyethylene glycol/
Tween 80, 90/5/5, vol/vol; closed bars) increases jejunal levels of HDA (F)
and HDE (G) in wild-type (+/+), but not in CD36 null (/) mice. open bars,
Vehicle (saline/polyethylene glycol/Tween 80, 90/5/5, vol/vol). *p < 0.05;
**p < 0.01; ***p < 0.001; n.s., not significantly different at p < 0.05; n = 5–6
per group. The data present the mean ± SEM.Cell Metabolism 8, 281–288, October 8, 2008 ª2008 Elsevier Inc. 283
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Enterocytes internalize diet-derived fatty acids at their apical cell
membrane and plasma-derived fatty acids at their basolateral
membrane. This process is functionally polarized, so that fatty
acids crossing the apical surface are channeled to different met-
abolic pathways than those crossing the basolateral surface: the
former are routed to chylomicron formation, while the latter are
utilized for intracellular b-oxidation and phospholipid remodeling
(Gangl and Ockner, 1975; Levin et al., 1992). The finding that
dietary oleic acid is a precursor for OEA prompted us to ask
whether plasma oleic acid may be used for the same purpose.
To address this question, we injected HDA in the peritoneum
of rats, thus allowing the tracer to access the intestinal mucosa
via the mesenteric circulation rather than the intestinal lumen.
Intraperitoneal HDA administration markedly increased HDA
levels in duodenal mucosa (Figure 4A), yet failed to produce
any detectable change in mucosal heptadecenoylethanolamide
content (Figure 4B). The results confirm that food-derived, rather
than plasma-derived, oleic acid serves as substrate for OEA
production.
OEA Signaling Mediates Fat-Induced Satiety
The entry of ingested fat into the duodenum triggers a feedback
mechanism that modulates feeding through activation of the
sensory vagus (Greenberg et al., 1990; Woltman and Reidel-
berger, 1995). Although release of CCK from enteroendocrine
cells may participate in this response, other as-yet-unidentified
mediators are also likely to be involved. Indeed, CCK receptor
antagonists only partially inhibit the anorexic effects elicited by
lipid infusion, particularly when higher lipid loads are adminis-
tered, implying the existence of a CCK-independent pathway
by which dietary fat regulates feeding (Meyer et al., 1998; Whited
et al., 2005; Woltman et al., 1995). To test whether OEA signaling
contributes to the satiating properties of fat, we assessed the im-
pact of duodenal Intralipid infusion on food intake in mutant C57/
BL6 mice lacking either CD36, which enables OEA mobilization,
or PPAR-a (Gonzalez et al., 1995), which mediates the anorexic
Figure 4. Plasma-Derived Oleic Acid Is Not Utilized for OEA Mobili-
zation
Intraperitoneal administration of the oleic acid analog 10Z-heptadecenoic acid
(HDA) (10 mg/kg) increases jejunal HDA levels (A) without affecting jejunal
heptadecenoylethanolamide (HDE) levels (B) V, vehicle (saline/polyethylene
glycol/Tween 80, 90/5/5, vol/vol, 2 ml/kg). ***p < 0.001; n = 6 per group. Values
are expressed as mean ± SEM.284 Cell Metabolism 8, 281–288, October 8, 2008 ª2008 Elsevier Inceffect of OEA. The lipid emulsion markedly reduced feeding in
wild-type CD57/Bl6 mice, but failed to do so in CD36 null
(Figure 5A) or PPAR-a null mutants (Figure 5B). The possibility
that free fatty acids derived from Intralipid digestion directly
activate intestinal PPAR-a (Bocos et al., 1995; Go¨ttlicher et al.,
1992) appears to be unlikely for three reasons: first, common
dietary fatty acids are approximately 1000-fold less potent
than OEA at activating PPAR-a (EC50 z100 mM for fatty acids
versus z100 nM for OEA) (Fu et al., 2003; Go¨ttlicher et al.,
1992); second, fatty acids are rapidly metabolized in enterocytes
(Mansbach and Gorelick, 2007), which would limit their ability to
act as signaling molecules; finally, and most importantly, intra-
peritoneal fatty acid injections exert no anorexic effect in rats
(Rodrı´guez de Fonseca et al., 2001), even though they increase
mucosal fatty acid content (Figures 3D and 3E), suggesting
that elevations in mucosal fatty acid levels are not sufficient to
evoke satiety. Thus, a more plausible explanation of our results
is that lipid infusions inhibit food intake by stimulating OEA
production. This interpretation views the conversion of dietary
oleic acid to OEA as an activating process that maximizes the
fatty acid’s ability to interact with PPAR-a.
OEA Signaling at PPAR-a Contributes
to Physiological Satiety
The insensitivity ofPPAR-a null mice to the anorexic effects of fat
infusions suggests that OEA signaling at PPAR-amay contribute
to the physiological induction of satiety. To address this possibil-
ity, we studied meal patterns (Gaetani et al., 2003) in wild-type
and PPAR-a null mice freely feeding on a standard lab chow.
PPAR-a null mice started their first nocturnal meal significantly
earlier than did wild-type controls (Figures 6A and 6B). In con-
trast, mice of the two genotypes consumed similar amounts of
food (PPAR-a null: 14.0 ± 3.3 g/kg; wild-type: 9.8 ± 1.9 g/kg;
p > 0.05, n = 10-12), over equivalent time periods (PPAR-a null:
2.1 ± 0.7 min; wild-type: 1.4 ± 0.4 min; p > 0.05, n = 10-12). In
addition, their blood glucose levels at dark onset were identical
(PPAR-a null: 142.8 ± 9.8 mg/dl; wild-type: 128.1 ± 7.8 mg/dl;
p > 0.05; n = 4). To gain further insight into the hyperphagic phe-
notype ofPPAR-a null mice, wemeasured satiety ratio (intermeal
Figure 5. CD36 and PPAR-a Mediate Fat-Induced Satiety
Duodenal infusion of the lipid emulsion Intralipid reduces intake of a liquid diet
(Ensure) in wild-type mice (+/+), but not CD36 null mice (/) (A) or PPAR-a
null mice (/) (B). Closed bars, Intralipid; open bars, saline. Intake is
expressed in ml/30min. **p < 0.01; n = 6–7. The data present the mean ± SEM..
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experienced by an animal per unit of food energy ingested.
During the first 3 hr of the night, PPAR-a null mice showedmark-
edly lower satiety ratio than did either wild-type C57/Bl6 mice
(Figure 6C) or mice of two different genetic strains (CD1, Sv/
129) (Table S1). Moreover, PPAR-a null mice fed more often
than did wild-type controls (Figure 6D), while eating comparable
amounts of food at each meal (PPAR-a null, 12.8 ± 0.8 g/kg;
wild-type, 9.7 ± 1.1 g/kg; p > 0.05, n = 12). These differences dis-
sipated after the fourth nocturnal meal, but resulted nonetheless
in significant changes in daily food intake (Figure 6E). Impor-
tantly, PPAR-a deletion had no significant influence on either
feeding-induced OEA mobilization (Figure 6F) or general behav-
ior. Various aspects of feeding behavior (food probing and eating
rate), motor and exploratory activity (open-field locomotion,
rearing) and fear-related responses (open-field thigmotaxis and
number of fecal boli) were similar in wild-type and PPAR-a null
mice (Figures 6G, 6H, and S6). We interpret these findings to
indicate that disruption of food-stimulated OEA signaling at
PPAR-a deactivates a physiological satietymechanism that con-
trols meal timing. Notably, this mechanism primarily operates
during the first hours of nocturnal feeding, when rodents eat
the first and largest of their daily meals.
Figure 6. OEA Signaling at PPAR-a Regu-
lates Normal Feeding
(A) Meal patterns in free-feeding wild-type mice
(open bars) and PPAR-a null mice (closed bars)
during the first 3 hr after dark onset (5:30 PM);
bar lengths symbolize the duration (± SEM) of
each meal. No difference in meal pattern was ob-
served between wild-type and PPAR-a null mice
after the fourth nocturnal meal (data not shown).
(B) Latency for the first meal (min).
(C) Satiety ratio values (min/g/kg) for the first four
meals.
(D) Meal frequency (meals/h) in the first 3 hr of
nocturnal feeding.
(E) Total food intake in 24 h (g/kg).
(F) No difference in feeding-induced jejunal OEA
mobilization in wild-type mice (+/+) and PPAR-
a null mice (/). FF, free-fed; FO, 24 hr food
deprivation; RF, 30 min refed after 24 hr food
deprivation.
(G) Number of food-probing episodes (non-eating
contacts with the food basket).
(H) Average eating rate (g/min) for the 24 hr obser-
vation period.
*p < 0.05; **p < 0.01; ***p < 0.001; n = 8–12. The
data present the mean ± SEM.
DISCUSSION
Our results suggest that dietary fat stimu-
lates small-intestinal enterocytes to pro-
duce OEA, which initiates in turn a local
PPAR-a-dependent response that delays
the start of a subsequent meal (Figure 7).
Three features of this model stand out.
The first centers on the mechanism gov-
erning OEA mobilization. We found that
this process is selectively elicited by fat, not protein or carbohy-
drate, and requires CD36, a membrane glycoprotein that binds
fatty acids and facilitates their transmembranemovements (Ehe-
halt et al., 2006). A role forCD36 as small-intestinal lipid sensor is
consistent with three known properties of this protein: (1) its
function as a taste receptor for unsaturated fatty acids in the
mouse oral cavity (Laugerette et al., 2005); (2) its localization to
the apical surface of enterocytes in rodent duodenum and jeju-
num (Poirier et al., 1996); and (3) its association with intracellular
protein kinases involved in signal transduction (Huang et al.,
1991). Our experiments, showing that CD36 deletion abolishes
OEAmobilization and that dietary oleic acid serves both as stim-
ulus and substrate for this reaction, indicate thatCD36may act in
the dual capacity as receptor and transporter for diet-derived
oleic acid. Through this two-fold action, CD36 may enable the
rapid conversion, hitherto unreported, of a lipid nutrient into a
cellular lipid signal.
A second feature of our model relates to the signaling modality
through which OEA regulates feeding. The still limited data avail-
able do not allow us to distinguish between two possible scenar-
ios. In one, OEA may act within small-intestinal enterocytes to
induce the release of a diffusible anorexic mediator (for example,
apolipoprotein A-IV, a secreted PPAR-a-regulated protein thatCell Metabolism 8, 281–288, October 8, 2008 ª2008 Elsevier Inc. 285
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Fat Intake to Across-Meal Satiety
According to this hypothetical model, CD36 local-
ized to the apical surface of small-intestinal enter-
ocytes recognizes luminal oleic acid (OA) derived
from the digestion of dietary fat and internalizes
it. (Top) Most newly absorbed OA is channeled
to the biosynthesis of triacylglycerol (TAG) and
phosphatidylcholine (PC) en route to chylomicron
formation. (Bottom) A small fraction of fatty acid
is converted into OEA, which activates PPAR-a
to prolong across-meal satiety and increase
expression of lipid-metabolizing genes. Dashed
arrows show that CD36 may further facilitate
OEA mobilization (1) by stimulating NOPE produc-
tion, presumably catalyzed by NAT activity; (2) by
enhancing NAPE-PLD activity, which converts
NOPE to OEA; and (3) by inhibiting FAAH activity,
which hydrolyzes OEA and terminates its actions.affects vagal activity and inhibits feeding) (Nagasawa et al.,
2007; Tso and Liu, 2004; Whited et al., 2005). Alternatively,
OEA may diffuse away from enterocytes to recruit neighboring
vagal afferents in the mucosal and submucosal layers of the
gut (Berthoud et al., 2004). Despite their differences, both sce-
narios posit that endogenous OEA targets PPAR-a located in
close proximity to its sites of production. The small-intestinal lo-
calization of this signaling mechanism, suggested by our duode-
nal infusion and sham-feeding experiments, does not exclude
the possibility that cephalic signals might modulate its function,
for example by influencing autonomic outflow to the gut (Lo
Verme et al., 2005). The existence of feed-back mechanisms
regulating OEAmobilization is further suggested by the observa-
tion that prolonged exposure to a diet enriched in oleic acid re-
duces small-intestinal OEA levels in rats (Artmann et al., 2008).
A third noteworthy point of the model pertains to the physio-
logical consequences of fat-stimulated OEA mobilization. We
found that targeted deletion of PPAR-a not only suppresses
the satiety response elicited by fat infusion, but also dramatically
shortens the interval between subsequent meals during the first
hours of normal feeding. These deficits are consistent with those
expected from disruption of OEA signaling at PPAR-a, and
suggest that endogenous OEA, by prolonging the intermeal
interval, may help minimize the metabolic challenge created by
the arrival of a fat-rich meal into the duodenum (Strubbe and
Woods, 2004; Woods, 1991). Such a protective mechanism
might cooperate with premeal insulin release and other cephalic
anticipatory responses (Strubbe and Woods, 2004) to optimize
lipid absorption and prepare the body for a subsequent meal.
Indeed, PPAR-a belongs to a cluster of nuclear receptors that
control the utilization of diet-derived lipid nutrients as fuels
(Bookout et al., 2006), and OEA activation of PPAR-a enhances
expression of lipid transporters and lipid-metabolizing enzymes
in enterocytes (Bu¨nger et al., 2007; Fu et al., 2003; Yang et al.,
2007).
In conclusion, our studies identify OEA as a key physiological
signal that specifically links dietary fat ingestion to across-meal
satiety. Nutritional and pharmacological strategies aimed at
magnifying this lipid-sensing mechanism, such as inhibitors of
OEA degradation, might be useful in the treatment of obesity
and other eating disorders.286 Cell Metabolism 8, 281–288, October 8, 2008 ª2008 Elsevier IncEXPERIMENTAL PROCEDURES
Chemicals
Reagent grade chemicals were used in all experiments. Peptone, sodium
oleate, sodium palmitate, and glucose were purchased from Sigma Aldrich
(St. Louis, MO, USA). Intralipid 10% was from Pharmacia-Upjohn (Bridge-
water, NJ). Vanilla Ensure liquid diet was obtained from Ross Product Division
(Abbott Laboratories, Abbott Park, IL, USA). Anandamide[ethanolamine-3H]
was from American Radiolabeled Chemicals (ARC, St. Louis, MO, USA). Syn-
theses of OEA, PEA and other chemicals are described in the Supplemental
Experimental Procedures.
Animals
Adult maleWistar rats (300 g) and adult male Sprague Dawley rats (300 g) were
purchased fromCharlesRiver (Wilmington,MA,USA).CD36 nullmice andwild-
type controls were a kind gift of Dr. Maria Febraio (Lerner Research Institute,
Cleveland, OH, USA). Male PPAR-a null mice (B6.129S4-PparatmtGonzN12)
and wild-type controls (C57/Bl6) were purchased from Taconic (Germantown,
NY, USA). Rats andmicewere individually housed in temperature and humidity
controlled roomson a 12 hr light/dark cycle, set with lights on at 5:30AM.Water
and standard chow pellets (Prolab RMH 2500, PMI Nutrition International,
Brentwood, MO, USA) were available ad libitum, except when animals were
food deprived. Food deprivation was conducted for 24 hr in bottom-wired ca-
ges toprevent coprophagia.All proceduresmet theNational Institutes ofHealth
Guidelines for the care and use of laboratory animals andwere approved by the
Institutional Animal Care and Use Committee of the University of California,
Irvine and of the Albert Einstein College of Medicine of Yeshiva University.
Surgery and Duodenal Infusions
Duodenal chronic in-dwelling silicone catheters were implanted in rats or mice
under ketamine/xylazine anesthesia (Azzara et al., 2002). After recovery, infu-
sions were conducted for 10 min at a rate of 0.5 ml/min (rats) or 0.01 ml/min
(mice). Nutrient concentrations were equicaloric at 2 kcal/ml. Additional surgi-
cal procedures are described in the Supplemental Experimental Procedures.
Lipid Analyses
Animals were sacrificed with halothane and tissues were rapidly collected and
snap-frozen in liquid N2. Frozen tissues were weighed and homogenized in
methanol (1 ml/100 mg tissue) containing the following internal standards:
[2H4]-OEA, [
2H4]-PEA, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-
N-heptadecanoyl (prepared as described in the Supplemental Experimental
Procedures), heptadecanoic acid, monoheptadecanoin, diheptadecanoin,
trinonadecenoin (Nu-Chek Prep, Elysian, MN) and 1,2-diheptadecanoyl-
sn-glycero-3-phosphocholine (Avanti Polar Lipids, Alabaster, AL, USA). Lipids
were extracted with chloroform (2 vol) and washed with water (1 vol). Organic
phases were collected and dried under liquid N2. Lipids were reconstituted in
chloroform/methanol (1:4, vol/vol, 0.1 ml) for LC/MS analyses. Lipid.
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OEA Links Fat Intake to Satietyidentification and quantification are described in the Supplemental Experimen-
tal Procedures.
Enzyme Assays
NAPE-PLD Activity
Duodenal and jejunal tissues, or the corresponding mucosal layers, were
removed and homogenized in ice-cold Tris-HCl (20 mM, [pH 7.4], 10 vol) con-
taining 0.32 M sucrose. Tissue homogenates were centrifuged at 10003 g for
10 min. NAPE-PLD activity was measured at 37C for 30 min in Tris-HCl buffer
(50 mM, [pH 7.4]) containing 0.1% Triton X-100, phenylmethylsulphonylfluor-
ide (1 mM), protein (100 mg) and 1,2-dipalmitoyl-sn-glycero-3-phosphoetha-
nolamine-N-heptadecenoyl (100 mM) as substrate. The reactions were
stopped by adding chloroform/methanol (2:1, vol/vol) containing [2H4]-OEA.
After centrifugation at 15003 g at 4C for 5 min, the organic layers were
collected and dried under liquid N2. The residues were suspended in chloro-
form/methanol (1:3, vol/vol, 50 ml) and analyzed by LC/MS. For quantification
purposes, we monitored the [M+Na]+ ions of heptadecanoylethanolamide
(mass-to-charge ratio, m/z, 334) and [2H4]-OEA (m/z, 352).
FAAH Activity
Tissues homogenates were centrifuged at 27,0003 g for 30 min, and pellets
suspended in phosphate-buffered saline (PBS [pH 7.4]). Reactions were con-
ducted at 37C for 30min in Tris-HCl buffer (50mM, [pH 8.0], 0.5ml) containing
fatty acid-free bovine serum albumin (0.05%), protein (50 mg) and anandami-
de[ethanolamine-3H] (10,000 dpm, specific activity 20 Ci/mmol). After stop-
ping the reactions with chloroform/methanol (1:1, vol/vol, 1 ml), we measured
radioactivity in the aqueous layers by liquid scintillation counting.
Feeding Behavior
Food intake in free-feeding mice was recorded using an automated monitoring
system, as previously described (Gaetani et al., 2003) with individual meals
defined using a minimum meal size criterion of 200 mg and a minimum inter-
meal interval criterion of 1 min. Liquid diet (Ensure) intake in mice was mea-
sured after a 6 hr daytime fast. Duodenal preloads were administered at a rate
of 0.01 ml/min for 10 min (2.0 kcal/ml) immediately prior to diet access. Intake
was measured at 15 min intervals for 30 min. Additional behavioral analyses
are described in the Supplemental Experimental Procedures.
Statistical Analyses
Results are expressed as the mean ± SEM of n separate experiments. The
significance of differences between groups was evaluated by one-way analy-
sis of variance (ANOVA) followed by a Dunnett’s test for multiple comparisons,
or Student’s t test with or without Welch’s correction. Analyses were done with
GraphPad Prism software (GraphPad Software, San Diego, CA, USA), and
differences were considered significant if p < 0.05.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, six
figures, and one table and can be found with this article online at http://
www.cellmetabolism.org/cgi/content/full/8/4/281/DC1/.
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